B · Normal
September 21st, Novo Nordisk aims to have sales of product lines under development exceed 150 billion Danish kroner in 2035.
Related telegraphs
[Jiangsu: From January to August, the added value of industries above designated
09-22 11:22
[Novo Nordisk responds to "Simeglutide reflux drugs": supports and fully coopera
09-22 11:06
On September 21, Novo Nordisk stated that Mexico is the next market for Wegovy o
09-21 20:59
On September 21, the head of Novo Nordisk in the United States said that since J
09-21 20:19
On September 21, Novo Nordisk’s Chief Scientific Officer (CSO) stated that at le
09-21 16:49
On September 21, the CEO of Novo Nordisk stated that it would launch new innovat
09-21 16:32
Comments